[title] | [date] | [link] | [market] | [doc type] | [stock code] | [stock name] |
EXCHANGE NOTICE - RESUMPTION OF TRADING | 21/01/2022 08:52 | Link | SEHK | htm | 00419 | HUAYI TENCENT |
VOLUNTARY ANNOUNCEMENT - PUBLICATION IN THE LANCET SHOWING THAT SCB-2019 (CPG 1018/ALUM) IN A PHASE 2/3 CLINICAL TRIAL DEMONSTRATES EFFICACY AGAINST ENTIRE SEVERITY SPECTRUM OF COVID-19 | 21/01/2022 08:20 | Link | SEHK | 02197 | CLOVER BIO-B | |
CLARIFICATION ANNOUNCEMENT, INSIDE INFORMATION AND RESUMPTION OF TRADING | 21/01/2022 08:06 | Link | SEHK | 00419 | HUAYI TENCENT | |
FORM OF ACCEPTANCE AND TRANSFER OF ORDINARY SHARE(S) IN THE ISSUED SHARE CAPITAL OF TIMES UNIVERSAL GROUP HOLDINGS LIMITED | 21/01/2022 08:03 | Link | SEHK | 02310 | TIMES UNI GP | |
OFFER DOCUMENT RELATING TO MANDATORY UNCONDITIONAL CASH OFFER BY ELSTONE SECURITIES LIMITED FOR AND ON BEHALF OF GREAT MATCH INTERNATIONAL LIMITED TO ACQUIRE ALL THE ISSUED SHARES IN TIMES UNIVERSAL GROUP HOLDINGS LIMITED (OTHER THAN THOSE ALREADY OWNED OR AGREED TO BE ACQUIRED BY GREAT MATCH INTERNATIONAL LIMITED AND PARTIES ACTING IN CONCERT WITH IT) | 21/01/2022 08:01 | Link | SEHK | 02310 | TIMES UNI GP | |
(1) CHANGE OF COMPANY NAME; (2) ADOPTION OF NEW COMPANY LOGO; AND (3) CHANGE OF COMPANY WEBSITE | 21/01/2022 08:00 | Link | SEHK | 00136 | HENGTEN NET | |
ISSUE OF HK$3,900 MILLION 4.95 PER CENT. SECURED GUARANTEED CONVERTIBLE BONDS DUE 2026 BY SMART INSIGHT INTERNATIONAL LIMITED | 21/01/2022 07:59 | Link | SEHK | 02007 | COUNTRY GARDEN | |
ISSUANCE OF U.S.$200,000,000 1.5 PER CENT. BONDS DUE 2023 | 21/01/2022 07:56 | Link | SEHK | 00218 | SWHYHK | |
INSIDE INFORMATION | 21/01/2022 07:30 | Link | SEHK | 03333 | EVERGRANDE | |
Transaction in own shares | 21/01/2022 06:52 | Link | SEHK | 00005 | HSBC HOLDINGS | |
VOLUNTARY ANNOUNCEMENT-ESTABLISHMENT OF JOINT VENTURE WITH BLUEPHA CO., LTD. | 21/01/2022 06:31 | Link | SEHK | 00460 | SIHUAN PHARM | |
DISCLOSEABLE TRANSACTION - ENTERING INTO THE AGREEMENT RELATING TO THE SALE OF TARGET SHARES | 21/01/2022 06:13 | Link | SEHK | 00489 | DONGFENG GROUP | |
VOLUNTARY ANNOUNCEMENT- RESULTS OF PHASE IB/II CLINICAL TRIAL OF CADONILIMAB (PD-1/CTLA-4 BI-SPECIFIC ANTIBODY) COMBINED WITH CHEMOTHERAPY AS FIRST-LINE THERAPY FOR ADVANCED GASTRIC CANCER/GASTROESOPHAGEAL JUNCTION CANCER PUBLISHED AT THE ASCO GI 2022 | 21/01/2022 06:13 | Link | SEHK | 09926 | AKESO-B | |
REPURCHASE AND REMITTANCE OF FUNDS FOR REPAYMENT OF 12.75% SENIOR NOTES DUE 2022 (the "2022 Notes", ISIN: XS2157244174; Common Code: 215724417; STOCK CODE: 40553) | 21/01/2022 06:08 | Link | SEHK | 06900 | SUNKWAN PPT | |
PREANNOUNCEMENT FOR 2021 ANNUAL RESULTS | 21/01/2022 06:08 | Link | SEHK | 00916 | CHINA LONGYUAN | |
ISSUE OF US$400,000,000 2.30% CREDIT ENHANCED BONDS DUE 2025 | 21/01/2022 06:08 | Link | SEHK | 03900 | GREENTOWN CHINA | |
LISTING OF A SHARES OF THE COMPANY AND AMENDMENTS TO ARTICLES OF ASSOCIATION AND RELEVANT RULES | 21/01/2022 06:05 | Link | SEHK | 00916 | CHINA LONGYUAN | |
Next Day Disclosure Return | 21/01/2022 06:05 | Link | SEHK | 03309 | C-MER EYE | |
VOLUNTARY ANNOUNCEMENT MEMORANDUM OF UNDERSTANDING | 20/01/2022 22:56 | Link | SEHK | 00767 | ZHONG JI LS | |
Terms of Reference for the Remuneration and Assessment Committee of the Board of Directors | 20/01/2022 22:48 | Link | SEHK | 00916 | CHINA LONGYUAN |
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Huayi Tencent Entertainment Corporation Limited published this content on 21 January 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 21 January 2022 01:01:05 UTC.